NorthWest Biotherapeutics Inc (NWBO)

[Rkmatters]

Thanks Ready, I've always been objective.

Other points of why it doesn't make sense to accept a halt:

They sincerely do not need to in Germany, as the HE allows them to treat GBM patients once enrollment is complete.

They get to practice Commercialization ramp up (which they told us would be slow), and which they'll need to scale up for full approval.

They may end up being invited to do step 2 of the EAMS. If they were invited, I imagine they'll take months before they apply as they will want to clean up UK site. But, eventually they would have that market also.

They can have months of revenue between completed enrollment and end of trial, so a halt would actually open them to as much risk in revenue then it would add.

Lastly, just because they don't announce a halt, it will not mean that the DMC didn't recommend it. :)

Happy holidays to you also.